Amgen (AMGN) says data from Phase 3 tests for its immune thrombocytopenia drug Nplate showed postitive results, and was presented at the 53rd Annual Meeting and Exposition of the American Society of Hematology over the weekend in San Diego.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at Benzinga.com (Thu, 1:25PM)
at Zacks.com (Thu, 11:20AM)
at Benzinga.com (Feb 11, 2015)
at Nasdaq.com (Feb 9, 2015)
at Nasdaq.com (Feb 6, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs